Volume | 118,460 |
|
|||||
News | - | ||||||
Day High | 49.45 | Low High |
|||||
Day Low | 47.10 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Soleno Therapeutics Inc | SLNO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
47.10 | 47.10 | 49.45 | 47.54 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,967 | 118,460 | $ 48.51 | $ 5,746,821 | - | 3.4801 - 53.82 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:28:30 | 1 | $ 49.54 | USD |
Soleno Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.56B | 32.46M | - | 0 | -38.99M | -1.20 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Soleno Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLNO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 37.73 | 53.80 | 37.09 | 44.93 | 1,030,356 | 11.72 | 31.06% |
1 Month | 40.96 | 53.80 | 36.61 | 42.23 | 469,811 | 8.49 | 20.73% |
3 Months | 46.48 | 53.82 | 36.61 | 43.90 | 382,313 | 2.97 | 6.39% |
6 Months | 23.90 | 53.82 | 21.30 | 40.18 | 349,701 | 25.55 | 106.90% |
1 Year | 3.60 | 53.82 | 3.4801 | 29.56 | 482,020 | 45.85 | 1,273.61% |
3 Years | 1.23 | 53.82 | 0.1302 | 6.22 | 871,650 | 48.22 | 3,920.33% |
5 Years | 2.02 | 53.82 | 0.1302 | 4.93 | 737,700 | 47.43 | 2,348.02% |
Soleno Therapeutics Description
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. |